Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device

An increasing number of countries have started to decriminalize or legalize the consumption of cannabis for recreational and medical purposes. The active ingredients in cannabis, termed cannabinoids, affect multiple functions in the human body, including coordination, motor skills, memory, response...

Full description

Bibliographic Details
Main Authors: Călin Trif, Dorin Harpaz, Evgeni Eltzov, Yardnapar Parcharoen, Chiravoot Pechyen, Robert S. Marks
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/14/3/126
_version_ 1827306927358476288
author Călin Trif
Dorin Harpaz
Evgeni Eltzov
Yardnapar Parcharoen
Chiravoot Pechyen
Robert S. Marks
author_facet Călin Trif
Dorin Harpaz
Evgeni Eltzov
Yardnapar Parcharoen
Chiravoot Pechyen
Robert S. Marks
author_sort Călin Trif
collection DOAJ
description An increasing number of countries have started to decriminalize or legalize the consumption of cannabis for recreational and medical purposes. The active ingredients in cannabis, termed cannabinoids, affect multiple functions in the human body, including coordination, motor skills, memory, response time to external stimuli, and even judgment. Cannabinoids are a unique class of terpeno-phenolic compounds, with 120 molecules discovered so far. There are certain situations when people under the influence of cannabis may be a risk to themselves or the public safety. Over the past two decades, there has been a growing research interest in detecting cannabinoids from various biological matrices. There is a need to develop a rapid, accurate, and reliable method of detecting cannabinoids in oral fluid as it can reveal the recent intake in comparison with urine specimens, which only show a history of consumption. Significant improvements are continuously made in the analytical formats of various technologies, mainly concerning improving their sensitivity, miniaturization, and making them more user-friendly. Additionally, sample collection and pretreatment have been extensively studied, and specific devices for collecting oral fluid specimens have been perfected to allow rapid and effective sample collection. This review presents the recent findings regarding the use of oral fluid specimens as the preferred biological matrix for cannabinoid detection in a point-of-care biosensor diagnostic device. A critical review is presented, discussing the findings from a collection of review and research articles, as well as publicly available data from companies that manufacture oral fluid screening devices. Firstly, the various conventional methods used to detect cannabinoids in biological matrices are presented. Secondly, the detection of cannabinoids using point-of-care biosensors is discussed, emphasizing oral fluid specimens. This review presents the current pressing technological challenges and highlights the gaps where new technological solutions can be implemented.
first_indexed 2024-04-24T18:30:41Z
format Article
id doaj.art-e70adb9547a74468bf177581aef672f9
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-04-24T18:30:41Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-e70adb9547a74468bf177581aef672f92024-03-27T13:28:11ZengMDPI AGBiosensors2079-63742024-02-0114312610.3390/bios14030126Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic DeviceCălin Trif0Dorin Harpaz1Evgeni Eltzov2Yardnapar Parcharoen3Chiravoot Pechyen4Robert S. Marks5Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, IsraelInstitute of Biochemistry, Food Science and Nutrition, Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, IsraelDepartment of Postharvest Science of Fresh Fruit, Volcani Center, Agricultural Research Organization, Rishon LeZion 7505101, IsraelChulabhorn International College of Medicine, Thammasat University, Klong Luang 12120, Pathum Thani, ThailandCenter of Excellence in Modern Technology and Advanced Manufacturing for Medical Innovation, Thammasat University, Klong Luang 12120, Pathum Thani, ThailandAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, IsraelAn increasing number of countries have started to decriminalize or legalize the consumption of cannabis for recreational and medical purposes. The active ingredients in cannabis, termed cannabinoids, affect multiple functions in the human body, including coordination, motor skills, memory, response time to external stimuli, and even judgment. Cannabinoids are a unique class of terpeno-phenolic compounds, with 120 molecules discovered so far. There are certain situations when people under the influence of cannabis may be a risk to themselves or the public safety. Over the past two decades, there has been a growing research interest in detecting cannabinoids from various biological matrices. There is a need to develop a rapid, accurate, and reliable method of detecting cannabinoids in oral fluid as it can reveal the recent intake in comparison with urine specimens, which only show a history of consumption. Significant improvements are continuously made in the analytical formats of various technologies, mainly concerning improving their sensitivity, miniaturization, and making them more user-friendly. Additionally, sample collection and pretreatment have been extensively studied, and specific devices for collecting oral fluid specimens have been perfected to allow rapid and effective sample collection. This review presents the recent findings regarding the use of oral fluid specimens as the preferred biological matrix for cannabinoid detection in a point-of-care biosensor diagnostic device. A critical review is presented, discussing the findings from a collection of review and research articles, as well as publicly available data from companies that manufacture oral fluid screening devices. Firstly, the various conventional methods used to detect cannabinoids in biological matrices are presented. Secondly, the detection of cannabinoids using point-of-care biosensors is discussed, emphasizing oral fluid specimens. This review presents the current pressing technological challenges and highlights the gaps where new technological solutions can be implemented.https://www.mdpi.com/2079-6374/14/3/126cannabiscannabinoidsoral fluiddiagnosticspoint-of-carebiosensors
spellingShingle Călin Trif
Dorin Harpaz
Evgeni Eltzov
Yardnapar Parcharoen
Chiravoot Pechyen
Robert S. Marks
Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device
Biosensors
cannabis
cannabinoids
oral fluid
diagnostics
point-of-care
biosensors
title Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device
title_full Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device
title_fullStr Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device
title_full_unstemmed Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device
title_short Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device
title_sort detection of cannabinoids in oral fluid specimens as the preferred biological matrix for a point of care biosensor diagnostic device
topic cannabis
cannabinoids
oral fluid
diagnostics
point-of-care
biosensors
url https://www.mdpi.com/2079-6374/14/3/126
work_keys_str_mv AT calintrif detectionofcannabinoidsinoralfluidspecimensasthepreferredbiologicalmatrixforapointofcarebiosensordiagnosticdevice
AT dorinharpaz detectionofcannabinoidsinoralfluidspecimensasthepreferredbiologicalmatrixforapointofcarebiosensordiagnosticdevice
AT evgenieltzov detectionofcannabinoidsinoralfluidspecimensasthepreferredbiologicalmatrixforapointofcarebiosensordiagnosticdevice
AT yardnaparparcharoen detectionofcannabinoidsinoralfluidspecimensasthepreferredbiologicalmatrixforapointofcarebiosensordiagnosticdevice
AT chiravootpechyen detectionofcannabinoidsinoralfluidspecimensasthepreferredbiologicalmatrixforapointofcarebiosensordiagnosticdevice
AT robertsmarks detectionofcannabinoidsinoralfluidspecimensasthepreferredbiologicalmatrixforapointofcarebiosensordiagnosticdevice